Results 231 to 240 of about 8,006,579 (361)
Separation of blast cell and T-lymphocyte progenitors in the blood of patients with acute myeloblastic leukemia [PDF]
MD Minden, RN Buick, E. A. McCulloch
openalex +1 more source
Prostate cancer is a leading malignancy with significant clinical heterogeneity in men. An 11‐gene signature derived from dysregulated epithelial cell markers effectively predicted biochemical recurrence‐free survival in patients who underwent radical surgery or radiotherapy.
Zhuofan Mou, Lorna W. Harries
wiley +1 more source
The Structural Biology of T-Cell Antigen Detection at Close Contacts. [PDF]
Lui Y+5 more
europepmc +1 more source
Clinical significance of stratifying prostate cancer patients through specific circulating genes
We tested a specific panel of genes representative of luminal, neuroendocrine and stem‐like cells in the blood of prostate cancer patients, showing predictive value from diagnosis to late stages of disease. This approach allows monitoring of treatment responses and outcomes at specific time points in trajectories.
Seta Derderian+12 more
wiley +1 more source
Modern Approach to Nodal T-Cell Lymphomas. [PDF]
Ondrejka SL, de Leval L, de Leval L.
europepmc +1 more source
MET variants in the N‐lobe of the kinase domain, found in hereditary papillary renal cell carcinoma, require ligand stimulation to promote cell transformation, in contrast to other RTK variants. This suggests that HGF expression in the microenvironment is important for tumor growth in such patients. Their sensitivity to MET inhibitors opens the way for
Célia Guérin+14 more
wiley +1 more source
Cell cycle, cell division, cell death
Jan M. Skotheim, Amy Shaub Maddox
openaire +2 more sources
Impact of genotypic variability of measles virus T-cell epitopes on vaccine-induced T-cell immunity. [PDF]
Emmelot ME+6 more
europepmc +1 more source
NUCLEOSIDE-PHOSPHORYLASE DEFICIENCY, AUTOIMMUNE HAEMOLYTIC ANAE MIA AND SELECTIVE T-CELL DEFICIENCY [PDF]
E. Carapella‐de Luca+8 more
openalex +1 more source
The complex mode of action of the topoisomerase II inhibitor etoposide in triggering apoptosis involves several mechanisms: overexpression of the mitochondrial protein VDAC1, leading to its oligomerization and formation of a large channel that mediates the release of pro‐apoptotic protein; and overexpression of the apoptosis regulators p53, Bax, and ...
Aditya Karunanithi Nivedita+1 more
wiley +1 more source